In another study, anaplastic lymphoma kinase (ALK) was proposed as a new MCC marker with one antibody clone (D5F3) demonstrating 94% sensitivity and 92% specificity for distinguishing MCC from SCLC [25]. This evidence concerns the gene ALK and small cell lung carcinoma.